Jacquelynn J. Cook - Concepedia

Author

Jacquelynn J. Cook

Also Known As

J Cook, J J Cook, J. Cook, J. J. COOK, J. J. Cook, J.J. Cook, Jacquelynn Cook, Jacquelynn J Cook, Jacquelynn J. Cook, Jacquelynn J. Cook

110

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Temple University

About

Jacquelynn J. Cook is an author at United States Military Academy specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	45	1.9K
2	Natural Sciences	16	18	911
3	Health Sciences	7	7	270
4	Social Sciences	4	4	119
5	Engineering	2	2	82

Jacquelynn J. Cook

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. J. Musial, Stefan Niewiarowski, Boguslaw Rucinski, Circulation Cell AdhesionPeptide SciencePharmacotherapyPlatelet ProtectionBiomedical Engineering	1990	134
In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232 Eric D. Hostetler, Aniket Joshi, Sandra Sanabria Bohórquez, Journal of Pharmacology and Experimental Therapeutics	2013	126
Metabolism-Directed Optimization of 3-Aminopyrazinone Acetamide Thrombin Inhibitors. Development of an Orally Bioavailable Series Containing P1 and P3 Pyridines Christopher S. Burgey, Kyle A. Robinson, Terry A. Lyle, Journal of Medicinal Chemistry Pharmaceutical ScienceOral BioavailabilityPharmacotherapyPharmaceutical ChemistryMolecular Pharmacology	2003	120
Design and Synthesis of a Series of Potent and Orally Bioavailable Noncovalent Thrombin Inhibitors That Utilize Nonbasic Groups in the P1 Position Thomas J. Tucker, Stephen F. Brady, William C. Lumma, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic ChemistryPharmacotherapyUtilize Nonbasic GroupsChemical Biology	1998	105
First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates Sethu Sankaranarayanan, Marie A. Holahan, Dennis Colussi, Journal of Pharmacology and Experimental Therapeutics	2008	105
Species Variability in Platelet and other Cellular Responsiveness to Thrombin Receptor-derived Peptides Thomas Connolly, Cindra Condra, Dong-Mei Feng, Thrombosis and Haemostasis ImmunologyMolecular BiologySpecies VariabilityHamster Thrombin ReceptorThrombosis	1994	99
An Antibody Against the Exosite of the Cloned Thrombin Receptor Inhibits Experimental Arterial Thrombosis in the African Green Monkey Jacquelynn J. Cook, Gary R. Sitko, Bohumil Bednář, Circulation	1995	94
Discovery and Evaluation of Potent P<sub>1</sub> Aryl Heterocycle-Based Thrombin Inhibitors Mary Beth Young, James C. Barrow, Kristen L. Glass, Journal of Medicinal Chemistry Molecular DockingCombinatorial ChemistryMedicinal ChemistryThrombin KDrug Target	2004	93
Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist Christopher Salvatore, Eric L. Moore, Amy Calamari, Journal of Pharmacology and Experimental Therapeutics	2010	88
A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody Helmut Glantschnig, Kevin R. Scott, Richard Hampton, Journal of Pharmacology and Experimental Therapeutics	2011	87

Page 1